Literature DB >> 6970189

Doxorubicin and daunorubicin modulation of macrophages, T and B lymphocytes (anthracycline lymphocyte modulation).

F R Orsini, E S Henderson.   

Abstract

Mouse spleen cells were cloned in the presence of phytohemagglutinin or lipopolysaccharide. The effects in vitro of doxorubicin or daunorubicin on colony formation were examined. At certain concentrations these drugs stimulated B lymphocytes and suppressed T lymphocytes. These were the opposite of the effects observed with in vivo drug administration. It was observed that soluble factors from drug-treated monocytes produced these effects. It was not clear whether the disparate effects were the result of two different monocytic populations or differences in the in vivo versus in vitro microenvironment present during drug administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970189     DOI: 10.1016/0162-3109(80)90021-1

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  2 in total

1.  Immunologic consequences of chemotherapy for acute myeloid leukemia.

Authors:  Anne Reilly; Leslie S Kersun; Eline Luning Prak; Jean Boyer; Kenyetta McDonald; Abbas F Jawad; Kathleen E Sullivan
Journal:  J Pediatr Hematol Oncol       Date:  2013-01       Impact factor: 1.289

2.  In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin.

Authors:  Richard D Olson; Mark B Headley; Alma Hodzic; Gerald M Walsh; Denise G Wingett
Journal:  Int Immunopharmacol       Date:  2007-02-14       Impact factor: 4.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.